Elsevier announces new partnership with CCS to publish the Canadian Journal of Cardiology

November 02, 2010

Ottawa, ON, Canada, 2 November, 20 10 - Elsevier, a world-leading publisher of scientific, technical, and medical information products and services, is pleased to announce a new partnership with the Canadian Cardiovascular Society and the January 2011 publication of the Canadian Journal of Cardiology, an established journal in the field of cardiovascular medicine.

Under the guidance of Editor-in-Chief Stanley Nattel, MD, FRSC, FRCPC, FACC, FHRS, Paul-David Chair in Cardiovascular Electrophysiology and Professor of Medicine at the University of Montreal and Director of the Electrophysiology Research Program at the Montreal Heart Institute Research Center, and a renowned Editorial Board, this internationally recognized journal publishes peer-review material pertinent to specialists, general practitioners, and cardiovascular scientists and addresses all aspects of cardiovascular medicine.

The Canadian Journal of Cardiology is the official journal of the Canadian Cardiovascular Society. It is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as a major venue for the results of Canadian cardiovascular research and Society guidelines. The Journal publishes original reports of clinical and basic research relevant to cardiovascular medicine as well as editorials, review articles, case reports, and papers on health outcomes, policy research, ethics, medical history, and political issues affecting practice.

"The Canadian Journal of Cardiology has been at the forefront in publishing clinical reports and research relevant to cardiovascular medicine for many years," comments Dr. Nattel, "we are confident that partnering with Elsevier will further our reach and impact in international cardiovascular circles. This is an exciting time for the CJC."

"The Canadian Journal of Cardiology has been and will continue to be the voice of our Society," says CCS President Charles Kerr. The Journal is a key benefit of Society membership. It serves as a vehicle of communication that reinforces the strength of not only the CCS, but the cardiovascular specialty as a whole."

The Canadian Journal of Cardiology will serve as a vehicle to enhance the dissemination of medical knowledge that will benefit people with cardiovascular disease.
-end-
About the Editor

Read more about Editor-in-Chief Dr. Stanley Nattel, MD, FRSC, FRCPC, FACC, FHRS, at:
http://pc33.uniklinikum-dresden.de:8080/enafra/portal/participants/stanley-nattel-md
http://www.med.mcgill.ca/pharma/displaypharma.asp?Pharma_ID=43
http://www.recherche.umontreal.ca/English/bulletin/2006November/Nattel.html

About The Canadian Cardiovascular Society

The Canadian Cardiovascular Society is the professional association for Canadian cardiovascular physicians and scientists working to promote cardiovascular health and care through knowledge translation, professional development, and leadership in health policy. The CCS provides programs and services to its 1900+ members and others in the cardiovascular community, including guidelines for cardiovascular care, the annual Canadian Cardiovascular Congress, and, with the Canadian Cardiovascular Academy, programs for trainees. More information about the CCS and its activities can be found at http://www.ccs.ca

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Elsevier

Related Medicine Articles from Brightsurf:

An ultrasonic projector for medicine
A chip-based technology that modulates intensive sound pressure profiles with high resolution opens up new possibilities for ultrasound therapy.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

How dinosaur research can help medicine
The intervertebral discs connect the vertebrae and give the spine its mobility.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Moving beyond 'defensive medicine'
Study shows removing liability concerns slightly increases C-section procedures during childbirth.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Protein injections in medicine
One day, medical compounds could be introduced into cells with the help of bacterial toxins.

Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine
Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to 'conventional medicine'.

Read More: Medicine News and Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.